The advent of immunotherapy has changed the way we treat cancer. But current techniques can only benefit some patients, and fare poorly against solid tumors. Cellular biologist Meghan Morrissey at UC Santa Barbara is working to change that by focusing on macrophages, a type of innate immune cell.